CVS Health Corporation
As of Fiscal Year 2025 (ended December 31, 2025)
Key KPIs at a Glance
| Metric | Value |
|---|---|
| Total revenue (FY2025) | $402.1 billion, up 7.8% year-over-year |
| Net income attributable to CVS Health (FY2025) | $1.77 billion (down from $4.61 billion in FY2024) |
| GAAP diluted EPS (FY2025) | $1.39 (vs. $3.66 in FY2024) |
| Adjusted EPS (FY2025) | $6.75 (vs. $5.42 in FY2024) |
| Medical benefit ratio -- Health Care Benefits/Aetna (FY2025) | 91.2% (improved from 92.5% in FY2024) |
| Medical membership -- Health Care Benefits (FY2025) | 26.6 million members |
| GAAP operating income by segment (FY2025) | Health Care Benefits: $1.79B; Health Services: $220M; Pharmacy & Consumer Wellness: $4.86B |
| Prescriptions filled/managed (FY2025, 30-day equivalent basis) | Health Services (PBM/Caremark): ~1.9 billion; Pharmacy & Consumer Wellness (retail): ~1.8 billion |
| Retail locations (as of Dec. 31, 2025) | Approximately 9,000 CVS Pharmacy retail locations |
| Employees (as of Dec. 31, 2025) | Over 300,000 colleagues, primarily in the U.S. |
Sources: All figures are company-disclosed, sourced from CVS Health Corporation's official Q4/full-year 2025 earnings release (filed as Exhibit 99.1 to Form 8-K, February 10, 2026) and the FY2025 Form 10-K (filed with the SEC, period ended December 31, 2025). Prior-year revenue figures (FY2021-FY2024) are from CVS Health's respective full-year earnings releases as filed with the SEC. No third-party estimates were used. Segment revenue figures include substantial intersegment revenue that is eliminated in consolidation, so segment revenues sum to well above total consolidated revenue -- this is normal and expected for CVS's structure (Health Services/Caremark and Pharmacy & Consumer Wellness both report revenue from filling prescriptions that are also counted by Health Care Benefits' plan sponsors, and intersegment pharmacy transactions between Caremark and CVS Pharmacy are eliminated at the consolidated level).